National Pension Service Sells 20,377 Shares of The Clorox Company (NYSE:CLX)

National Pension Service lessened its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 8.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 215,276 shares of the company's stock after selling 20,377 shares during the period. National Pension Service owned 0.17% of Clorox worth $35,071,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. First Foundation Advisors acquired a new stake in Clorox in the 1st quarter valued at approximately $31,000. Innealta Capital LLC acquired a new stake in shares of Clorox in the second quarter worth $30,000. Trifecta Capital Advisors LLC increased its position in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after acquiring an additional 130 shares during the period. Quarry LP raised its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. bought a new stake in Clorox in the 2nd quarter valued at $31,000. Institutional investors own 78.53% of the company's stock.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.57% of the company's stock.

Clorox Price Performance

Shares of NYSE:CLX traded up $0.15 during trading on Thursday, reaching $162.85. The stock had a trading volume of 994,721 shares, compared to its average volume of 1,244,513. The stock has a market capitalization of $20.16 billion, a PE ratio of 56.71, a P/E/G ratio of 3.02 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $169.09. The business's 50-day moving average price is $161.89 and its 200 day moving average price is $146.58.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same period in the previous year, the business posted $0.49 earnings per share. The firm's revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, equities analysts predict that The Clorox Company will post 6.81 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. Clorox's payout ratio is presently 170.04%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CLX. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a report on Friday, November 1st. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and boosted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI reduced their target price on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.